|
Research that Palatin Technologies has conducted on PT141 shows that PT141
works by activating melanocortin receptors in the central nervous system rather
than by activating the vascular system. Activation of the melanocortin receptors
causes vasodilatation (increased blood flow) to the genital area. This method of
delivery is different from the sexual enhancement drugs currently on the market
such as Viagra, Levitra, and Cialis which focus mainly on increasing blood flow
to the penis without affecting the central nervous system. PT141 works on the
central nervous system by interacting more with the brain’s and central nervous
system’s role in sexual arousal and response. It is believed that this effect is
a more natural method of penile erection. An advantage to PT141 over other male
sexual enhancement drugs is that is works quicker and lasts longer as has been
shown in studies conducted by Palatin Technologies. Another benefit is that it
acts on the pathway that controls sexual function and desire (central nervous
system) which makes it safer and more effective than current sexual enhancement
drugs on the market.
How PT141
works
Because PT141 directly targets the brain’s arousal center and doesn’t just work
with the vascular system to increase blood flow to the genital area, it has the
potential to treat women with sexual dysfunction problems, especially those with
lack of sexual desire.
For women, PT141 works twofold in that it increases sexual desire and function.
For men it is primarily is used for erectile dysfunction (ED), but for women it
has been shown to increase the desire for sex and well as the enjoyment of sex.
PT141 is taken approximately 30 minutes before sexual activity and is nasally
administered. It is non-invasive and fast acting. PT141 does not interact with
other drugs, food or alcohol and has minimal side effects.
|
|
